SEC Form 4 · accession 0001179110-18-002653

Tabula Rasa HealthCare, Inc. · TRHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Bruce Luehrs

Director

Period of report

Feb 20, 2018

Accepted (ET)

Feb 22, 2018 · 7:21 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001651561

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F5,F2,F3	Feb 20, 2018	S	26,319	$34.73	D	459,523	I	See footnotes
Common Stock^F6,F2,F3	Feb 20, 2018	S	30,875	$35.39	D	428,648	I	See footnotes
Common Stock^F7,F2,F3	Feb 20, 2018	S	22,285	$36.42	D	406,363	I	See footnotes
Common Stock^F8,F2,F3	Feb 20, 2018	S	1,357	$37.17	D	405,006	I	See footnotes
Common Stock^F9,F2,F3	Feb 21, 2018	S	73,824	$34.56	D	331,182	I	See footnotes
Common Stock^F10,F2,F3	Feb 21, 2018	S	8,322	$35.09	D	322,860	I	See footnotes
Common Stock^F11,F2,F3	Feb 22, 2018	S	3,400	$31.78	D	319,460	I	See footnotes
Common Stock^F12,F2,F3	Feb 22, 2018	S	47,030	$32.59	D	272,430	I	See footnotes
Common Stock^F13,F2,F3	Feb 22, 2018	S	37,795	$33.37	D	234,635	I	See footnotes
Common Stock^F14,F2,F3	Feb 22, 2018	S	1,035	$34.26	D	233,600	I	See footnotes
Common Stock^F1	holding	—	—		—	8,161	D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1Includes a restricted stock award of 3,710 shares of the Company's common stock received by Bruce Luehrs on September 28, 2016, of which shares 1,236 are vested and 2,474 are unvested. Also includes a restricted stock award of 1,855 shares of the Company's common stock received by Bruce Luehrs on September 28, 2016, all of which are vested. Also includes a restricted stock award of 2,596 shares of the Company's common stock received by Bruce Luehrs on June 16, 2017. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant.
F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (10) to this Form 4.
F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.64 to $31.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (11) to this Form 4.
F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $32.02 to $32.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (12) to this Form 4.
F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.00 to $33.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (13) to this Form 4.
F14The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.01 to $34.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (14) to this Form 4.
F2These securities are held by Emerald Stage2Ventures, L.P. Stage2 Capital Ventures Associates, L.P. is the general partner of Emerald Stage2 Ventures, L.P. and Stage2 Capital Associates G.P., LLC is the general partner of Stage2 Capital Ventures Associates, L.P. Bruce Luehrs, who serves as a director of the Issuer, is an officer of Stage2 Capital Associates G.P., LLC.
F3The Reporting Person disclaims beneficial ownership (as defined in Rule 16a-1(a)(2)) of the securities reported herein (except to the extent of his pecuniary interest in such securities), and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F4This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Emerald Stage2Ventures, L.P. on January 26, 2018.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.12 to $34.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (5) to this Form 4.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (6) to this Form 4.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.00 to $36.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (7) to this Form 4.
F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $37.00 to $37.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (8) to this Form 4.
F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.05 to $34.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (9) to this Form 4.